BEONE MEDICINES LTD. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
BEONE MEDICINES LTD. (ONC) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $137.41 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital › APIC, Share-Based Payment Arrangement, Increase for Cost Recognition
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2026-08-05
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-06-30 was $137.41M, a 8.89% decline year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2026-03-31 was $123.36M, a 29.20% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-09-30 was $140.81M, a 22.77% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for the quarter ending 2025-06-30 was $150.81M, a 15.44% increase year-over-year.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2025 was $510.86M, a 15.68% increase from fiscal 2024.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2024 was $441.62M, a 20.13% increase from fiscal 2023.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2023 was $367.62M, a 21.26% increase from fiscal 2022.
- BEONE MEDICINES LTD. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2022 was $303.16M, a 25.94% increase from fiscal 2021.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 9 month | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|---|---|---|
| 2026-06-30 | $137.41M 10-Q · filed 2026-08-05 | $260.76M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2026-03-31 | $123.36M 10-Q · filed 2026-08-05 | |||
| 2025-12-31 | $510.86M 10-K · filed 2026-02-26 | |||
| 2025-09-30 | $140.81M 10-Q · filed 2025-11-06 | $291.62M derived: sum of 2 quarters · filed 2026-08-05 | $387.10M derived: sum of 3 quarters · filed 2026-08-05 | |
| 2025-06-30 | $150.81M 10-Q · filed 2026-08-05 | $246.29M derived: sum of 2 quarters · filed 2026-08-05 | ||
| 2025-03-31 | $95.48M 10-Q · filed 2026-08-05 | |||
| 2024-12-31 | $441.62M 10-K · filed 2026-02-26 | |||
| 2024-09-30 | $114.70M 10-Q · filed 2025-11-06 | $245.33M derived: sum of 2 quarters · filed 2025-11-06 | $334.00M derived: sum of 3 quarters · filed 2025-11-06 | |
| 2024-06-30 | $130.64M 10-Q · filed 2025-11-06 | $219.30M derived: sum of 2 quarters · filed 2025-11-06 | ||
| 2024-03-31 | $88.67M 10-Q · filed 2025-11-06 | |||
| 2023-12-31 | $367.62M 10-K · filed 2026-02-26 | |||
| 2023-09-30 | $96.00M 10-Q · filed 2024-11-12 | $199.38M derived: sum of 2 quarters · filed 2024-11-12 | $274.70M derived: sum of 3 quarters · filed 2024-11-12 | |
| 2023-06-30 | $103.37M 10-Q · filed 2024-11-12 | $178.69M derived: sum of 2 quarters · filed 2024-11-12 | ||
| 2023-03-31 | $75.32M 10-Q · filed 2024-11-12 | |||
| 2022-12-31 | $303.16M 10-K · filed 2023-02-27 | |||
| 2021-12-31 | $240.71M 10-K · filed 2023-02-27 | |||
| 2020-12-31 | $183.48M 10-K · filed 2023-02-27 | |||
| 2019-12-31 | $134.15M 10-K · filed 2022-02-28 |